Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ACHL

Achilles Therapeutics (ACHL) Stock Price, News & Analysis

Achilles Therapeutics logo

About Achilles Therapeutics Stock (NASDAQ:ACHL)

Advanced Chart

Key Stats

Today's Range
$1.48
$1.48
50-Day Range
$1.48
$1.48
52-Week Range
$0.63
$1.51
Volume
N/A
Average Volume
744,051 shs
Market Capitalization
$60.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ACHL Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

ACHL Stock Analysis - Frequently Asked Questions

Achilles Therapeutics plc (NASDAQ:ACHL) issued its earnings results on Wednesday, August, 14th. The company reported ($0.41) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.41).

Achilles Therapeutics (ACHL) raised $176 million in an initial public offering (IPO) on Wednesday, March 31st 2021. The company issued 9,800,000 shares at a price of $17.00-$19.00 per share. JPMorgan, BofA Securities, Piper Sandler, Chardan, Oppenheimer & Co. and Kempen & Co. acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Achilles Therapeutics investors own include Digital Turbine (APPS), Aquestive Therapeutics (AQST), CRISPR Therapeutics (CRSP), ChargePoint (CHPT) and NVIDIA (NVDA).

Company Calendar

Last Earnings
8/14/2024
Today
8/02/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ACHL
CIK
1830749
Fax
N/A
Employees
250
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$69.67 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-54.45%
Return on Assets
-47.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.04
Quick Ratio
6.04

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.49 per share
Price / Book
0.42

Miscellaneous

Outstanding Shares
41,100,000
Free Float
38,889,000
Market Cap
$60.83 million
Optionable
Not Optionable
Beta
1.25
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ACHL) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners